These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7286067)

  • 21. Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.
    Jayasimhan A; Mansour KP; Slattery RM
    Clin Sci (Lond); 2014 Jan; 126(1):1-18. PubMed ID: 24020444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alloxan diabetes on kidney growth in intact and castrated mice.
    Broulik PD; Schreiber V
    Acta Endocrinol (Copenh); 1982 Jan; 99(1):109-11. PubMed ID: 6174007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
    Wicker LS; Miller BJ; Mullen Y
    Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormones and lupus].
    Gompel A; Pelissier C; Kuttenn F; Mauvais-Jarvis P
    Rev Med Interne; 1985 Dec; 6(5):543-52. PubMed ID: 3914021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The non-obese diabetic (NOD) mouse.
    Leiter EH; Prochazka M; Coleman DL
    Am J Pathol; 1987 Aug; 128(2):380-3. PubMed ID: 3303953
    [No Abstract]   [Full Text] [Related]  

  • 26. Sex differences in the multiple-dose streptozotocin model of diabetes.
    Rossini AA; Williams RM; Appel MC; Like AA
    Endocrinology; 1978 Oct; 103(4):1518-20. PubMed ID: 154403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free fatty acid profiles in the non-obese diabetic (NOD) mouse: basal serum levels and effects of endocrine manipulation.
    Christeff N; Homo-Delarche F; Thobie N; Durant S; Dardenne M; Nunez EA
    Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):125-31. PubMed ID: 7972266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.
    Prochazka M; Serreze DV; Worthen SM; Leiter EH
    Diabetes; 1989 Nov; 38(11):1446-55. PubMed ID: 2576007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin autoantibodies in mouse models of insulin-dependent diabetes.
    Maruyama T; Takei I; Asaba Y; Yanagawa T; Takahashi T; Itoh H; Suzuki Y; Kataoka K; Saruta T; Ishii T
    Diabetes Res; 1989 Jun; 11(2):61-5. PubMed ID: 2620486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
    Reddy S; Chang M; Robinson E
    Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
    Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.
    Yasunami R; Bach JF
    Eur J Immunol; 1988 Mar; 18(3):481-4. PubMed ID: 2965652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.
    Wicker LS; Miller BJ; Coker LZ; McNally SE; Scott S; Mullen Y; Appel MC
    J Exp Med; 1987 Jun; 165(6):1639-54. PubMed ID: 3585250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice.
    Saravia FE; Revsin Y; Gonzalez Deniselle MC; Gonzalez SL; Roig P; Lima A; Homo-Delarche F; De Nicola AF
    Brain Res; 2002 Dec; 957(2):345-53. PubMed ID: 12445977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
    LaFace DM; Peck AB
    Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin modulates the incidence of diabetes in male and female NOD mice.
    Hawkins TA; Gala RR; Dunbar JC
    Autoimmunity; 1994; 18(3):155-62. PubMed ID: 7858100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models utilized in the research of diabetes mellitus--with special reference to insulitis-associated diabetes.
    Tarui S; Yamada K; Hanafusa T
    Prog Clin Biol Res; 1987; 229():211-23. PubMed ID: 2955426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NOD mouse as a model of type I diabetes.
    Tochino Y
    Crit Rev Immunol; 1987; 8(1):49-81. PubMed ID: 2961513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of high- and low-diabetes-incidence NOD mouse strains.
    Baxter AG; Adams MA; Mandel TE
    Diabetes; 1989 Oct; 38(10):1296-300. PubMed ID: 2529158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.